openPR Logo
Press release

Neuroendovascular Coil Market Volume Forecast and Value Chain Analysis 2016-2024

05-10-2017 06:58 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Neuroendovascular Coil Market Volume Forecast and Value Chain

Neuroendovascular coiling is performed to prevent the blood flow in an aneurysm. An aneurysm is the excessive enlargement of blood vessels lead to a weakness of the blood vessel wall. This helps by sealing the aneurysm, promoting blood clotting around the coils and reducing pressure on its outer wall. The endovascular coiling treatment is usually performed under general anesthesia by a neurosurgeon or an interventional neuroradiologist using fluoroscopic imaging guidance. The coil is left behind and placed permanently in the aneurysm. Coiling is performed for both the ruptured aneurysms and unruptured aneurysms. Neuroendovascular coils are used as an alternative effective treatment to surgical clipping in an aneurysm. This neuroendovascular coiling helps in the prevention of subarachnoid hemorrhage, which leads to stroke, severe complications and even death. A number of factors can contribute for developing an aneurysm and weakness in an artery wall such as old age, smoking, high blood pressure, drug abuse, head injuries, heavy alcohol consumption, certain blood infection, low estrogen level and many other factors. Diagnosis of the ruptured aneurysms can be done by the computed tomography (CT) scan after the signs of the subarachnoid hemorrhage. If computed tomography scan shows negative signs then a lumbar puncture can be performed to detect blood in the cerebrospinal fluid to confirm an aneurysm. The computed tomography angiography (CTA) is also widely performed to detect and analyzed the aneurysm.

This report gives readers a comprehensive overview of the Neuroendovascular Coil Market. Browse to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/neuroendovascular-coil-market.html

Global neuroendovascular coiling market has been segmented by product type, indication, end user, and geography. In term of product type, the market has been categorized into Guglielmi Detachable Coils (GDC) and Matrix coils. Guglielmi detachable coil is made of the platinum. Matrix coils are of two types biopolymer coated and hydrogel coated. Matrix coils are highly demanded and are more effective than guglielmi detachable coils. Based on the indication global neuroendovascular coil market is segmented in ruptured aneurysms and unruptured aneurysms. End user for the neuroendovascular coils includes hospitals, stroke center and ambulatory surgical centers. Hospitals are further sub- segmented into 500 plus beds hospitals, 250 to 499 beds hospitals and less than 250 beds hospitals.

Geographically, the Neuroendovascular Coil market has been segmented into five regional markets, namely, North America (United States and Canada), Europe (Germany, France, United Kingdom, etc.), Asia-Pacific (Australia, China, Japan, India, etc.), Latin America (Mexico, Brazil etc.) and Middle East and Africa (Saudi Arabia, UAE, South Africa etc.). North America was observed as the largest market, in terms of revenue for neuroendovascular coil. North America was followed by Europe and is expected to register higher growth. Emerging markets such as Asia Pacific, Latin America and the Middle East and Africa are expected to record robust growth during the forecast period 2016-2024 due to growing health care industry, and aging population which consequently would lead to increased patient population in these countries. India, China, and Brazil are expected to drive strong growth among the emerging countries, owing to increasing investments by government bodies in order to enhance healthcare facilities.

In addition, there are number of factors that would affect the growth of the neuroendovascular coil market such as, high incidence of brain aneurysms, technological advancement, increase in the number of stroke patients and awareness about health in developing countries. The market is also experiencing certain restraints, such as, risk of complication in neurovascular procedures, stiff competition among existing neuroendovascular coil manufacturers, subsequent upswing in bulk purchasing through GPOs (Group Purchasing Organizations) and government regulations for reduction of overall healthcare cost.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Neuroendovascular Coil Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14324

The major players operating in the neuroendovascular coil market include Medtronic, Stryker, Cardinal Health, Penumbra, Inc., Johnson & Johnson Services, Inc., Boston Scientific, Cook Medical Inc., and Terumo Corporation.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuroendovascular Coil Market Volume Forecast and Value Chain Analysis 2016-2024 here

News-ID: 529322 • Views: …

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…

All 5 Releases


More Releases for Neuroendovascular

Neuroendovascular Coils Market to See Massive Growth by 2028
Neuroendovascular Coils Market was valued at USD Billion in 2023 and is expected to grow at a CAGR of 29% between 2024 and 2031. Every business needs to understand its customers', their buying habits; behavior and expectations and Neuroendovascular Coils Market research report greatly helps in this regard by doing detailed research on market and bringing right information to the key participants. Such an efficient and detailed Neuroendovascular Coils Market…
Innovations in Neuroendovascular Coils Market Revolutionizing Cerebrovascular Tr …
Advancements in medical technology have propelled the field of neuroendovascular treatment to new heights, providing innovative solutions for patients suffering from cerebrovascular diseases. One such groundbreaking development is the Neuroendovascular Coil Market, a rapidly expanding sector that is transforming the landscape of interventional radiology and neurosurgery. This article explores the current state of the neuroendovascular coil market, its significant impact on patient care, and the future prospects of this cutting-edge…
Competitors Analysis of Neuroendovascular Coil Market from 2020 to 2025
GLOBAL INFO RESEARCH has recently published a research report titled, [Global Neuroendovascular Coil Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025] assessing various factors impacting its trajectory. Analysts have used primary and secondary research methodologies to determine the path of the market. The data includes historic and forecast values for a well-rounded understanding. The global Neuroendovascular Coil market is expected to augment in the forecast period owing to various…
Neuroendovascular Coil Market Global Forecast to 2026
Neuroendovascular coil is a device, which is widely used for the treatment of aneurysms. Aneurysm is a disorder that occurs when an artery's wall weakens and causes an abnormal bulge. There are two types of aneurysms that can be treated using neuroendovascular coil namely, ruptured aneurysms and unruptured aneurysms. Ruptured aneurysms are those, which releases blood into the subarachnoid space around the brain and unruptured aneurysms do not rupture and…
Neuroendovascular Coil Market Global Industry Volume By Region 2016 - 2024
Neuroendovascular coiling is performed to prevent the blood flow in an aneurysm. An aneurysm is the excessive enlargement of blood vessels lead to a weakness of the blood vessel wall. This helps by sealing the aneurysm, promoting blood clotting around the coils and reducing pressure on its outer wall. The endovascular coiling treatment is usually performed under general anesthesia by a neurosurgeon or an interventional neuroradiologist using fluoroscopic imaging guidance.…
Global Neuroendovascular Non-coil Sales Market Report 2017
This report studies sales (consumption) of Neuroendovascular Non-coil in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Boston Scientific Sorin Terumo Stryker To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=948168&type=E Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of…